Jazz Pharmaceuticals' Lung Cancer Setback: Stock Impact
A late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
This article compares index fund choices for retirement in 2024, focusing on S&P 500 vs Total Market performance and cost considerations.
24,804 articlesA late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
U.S. stocks attempt to regain momentum on June 24, 2026, as investors digest fresh earnings and AI demand signals. Th...
Meta documents reveal plans to launch an AI-powered prediction market app using play money. The move could reshape ho...
A sudden stock pullback creates a rare entry point for patient investors. The company combines non-discretionary serv...
In a choppy market, one defense contractor shines as a rare dividend stock built for downturns. Its government-backed...
SharpLink Gaming resumes ETH purchases after eight months, fueling a renewed ethereum price prediction: forgotten con...
A hard look at how scammers recruit money mules, the risks for seniors, and concrete steps you can take to shield you...
Apple's push into on-device AI could change how we think about upgrades and long-term value. This guide outlines what...
A powerful shift is forming: auto plants turning into energy storage hubs to power data centers and grids. This unsto...
The Supreme Court declined to hear Alan Dershowitz's $300 million defamation suit against CNN, ending a high-profile ...
Meta is pursuing a new play-money prediction market, Arena, designed to test engagement and data signals while naviga...
A surge in investor interest centers on SPCX as SpaceX expands its orbit into launches, satellite networks, and AI ve...